Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
Spotlight survey: flow cytometry in bioanalysis TAKE THE SURVEY

Why flow cytometry at KCAS? Solving the mysteries of flow cytometry

2 Jul 2018
General interest

KCAS has invested time and resources to qualify a number of multi-parameter immunophenotyping panels which can be utilized ‘off the shelf’ or customized to meet our client’s particular needs.

LB_Q3-spotlight-view

Top content

  • Chad Briscoe on emerging trends and updates in the biomarker area
  • Blood biomarker panel enhances detection of pancreatic cancer compared to measuring CA19-9 levels alone
  • An automated preanalytical system for oral fluid drug testing

Related tags

biomarker validation KCAS
Previous article Next article

Related articles

27 NOV 2018 GENERAL INTEREST
Immunogenicity services and capabilities at KCAS Bioanalytical & Biomarker Services
4 FEB 2018 BIOMARKERS
In the Zone: immuno-oncology
13 JUN 2018 GENERAL INTEREST
The facts, frustrations and future hopes for immuno-oncology: a podcast with Dr Dominic Warrino (KCAS)
27 SEP 2018 GENERAL INTEREST
Immunogenicity assay development
25 JUL 2023 INTERVIEWS
Highlights from the 2023 WRIB conference and a look to the future for biomarkers from Jian Wang
29 MAY 2018 LARGE MOLECULES
Top 5 techniques and tips for choosing old vs new technologies
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Bioanalysis Zone